| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacodynamic Interaction of Coadministered Amlodipine and Atorvastatin in 1660 Patients With Concomitant Hypertension and Dyslipidemia: The Respond Trial
|
Preston, Richard A.
|
|
2007
|
47 |
12 |
p. 1555-1569
|
article
|
| 2 |
A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q10 (Ubiquinone)
|
Constantinescu, Radu
|
|
2007
|
47 |
12 |
p. 1580-1586
|
article
|
| 3 |
Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic-Controlled Extended-Release Methylphenidate Formulation in Humans
|
Parasrampuria, Dolly A.
|
|
2007
|
47 |
12 |
p. 1476-1488
|
article
|
| 4 |
BookReview: Abdel-Magid AF, Caron S. Fundamentals of Early Clinical Drug Development: From Synthesis Design to Formulation. New York: John Wiley; 2006; 323 pp
|
Bhattacharjee, K.R.
|
|
2007
|
47 |
12 |
p. 1594-1594
|
article
|
| 5 |
BookReview: Books Available for Review
|
|
|
2007
|
47 |
12 |
p. 1594-1594
|
article
|
| 6 |
BookReview: Dubovsky SL, Dubovsky AN. Psychotropic Drug Prescriber's Survival Guide: Ethical Mental Treatment in the Age of Big Pharma. New York: W. W. Norton; 2007; 187 pp., $27.50
|
|
|
2007
|
47 |
12 |
p. 1592-1593
|
article
|
| 7 |
BookReview: Letter From the Section Editor
|
|
|
2007
|
47 |
12 |
p. 1594-1594
|
article
|
| 8 |
BookReview: Moyé LA. Statistical Reasoning in Medicine: The Intuitive P-Value Primer. 2nd ed. New York: Springer; 2006; 301 pp., $54.95
|
Korth-Bradley, Joan
|
|
2007
|
47 |
12 |
p. 1593-1593
|
article
|
| 9 |
Commentary on ACCP Position Statement on the Use of Microdosing in the Drug Development Process
|
Rowland, Malcolm
|
|
2007
|
47 |
12 |
p. 1595-1596
|
article
|
| 10 |
Drug Interaction Studies of Therapeutic Proteins or Monoclonal Antibodies
|
Mahmood, Iftekhar
|
|
2007
|
47 |
12 |
p. 1540-1554
|
article
|
| 11 |
Effect of High-Dose Metronidazole on Pharmacokinetics of Oral Budesonide and Vice Versa: A Double Drug Interaction Study
|
Dilger, Karin
|
|
2007
|
47 |
12 |
p. 1532-1539
|
article
|
| 12 |
Effects of Etoricoxib and Comparator Nonsteroidal Anti-Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium Diet
|
Schwartz, Jules I.
|
|
2007
|
47 |
12 |
p. 1521-1531
|
article
|
| 13 |
Highlightsand Book Review: Bansal S, DeStefano A. Key elements of bioanalytical method validation for small molecules. AAPS J. 2007;9:Article 11
|
|
|
2007
|
47 |
12 |
p. 1590-1590
|
article
|
| 14 |
Highlightsand Book Review: Barrett JS, Gupta M, Mondick JT. Model-based drug development applied to oncology. Expert Opin Drug Discov. 2007;2:185-209. Kummar S, Gutierrez M, Doroshow JH, Murgo A. Drug development in oncology: classic cytotoxics and molecularly targeted agents. Br J Clin Pharmacol. 2006;62:15-26
|
|
|
2007
|
47 |
12 |
p. 1588-1588
|
article
|
| 15 |
Highlightsand Book Review: Bauer RJ, Guzy S, Ng C. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples. AAPS J. 2007; 9:Article 7
|
|
|
2007
|
47 |
12 |
p. 1588-1589
|
article
|
| 16 |
Highlightsand Book Review: Ellenbogen JM, Hu PT, Payne JD, Titone D, Walker M. Human relational memory requires time and sleep. Proc Natl Acad Sci USA. 2007;104:7723-7728
|
|
|
2007
|
47 |
12 |
p. 1589-1590
|
article
|
| 17 |
Highlightsand Book Review: Kallen A. A simple absorption model for dose-escalating studies. J Pharmacokinet Pharmacodyn. 2007;34:251-261
|
|
|
2007
|
47 |
12 |
p. 1591-1591
|
article
|
| 18 |
Highlightsand Book Review: Liu M, Wei L, Zhang J. Review of guidelines and literature for handling missing data in longitudinal clinical trials with a case study. Pharm Stat. 2006;5:7-18
|
|
|
2007
|
47 |
12 |
p. 1591-1591
|
article
|
| 19 |
Highlightsand Book Review: Ludbrook J. Writing intelligible prose for biomedical journals. Clin Exp Pharmacol Physiol. 2007;34:508-514
|
|
|
2007
|
47 |
12 |
p. 1591-1591
|
article
|
| 20 |
Highlightsand Book Review: Research Highlights
|
Bonate, Peter L.
|
|
2007
|
47 |
12 |
p. 1587-1587
|
article
|
| 21 |
Highlightsand Book Review: Reynolds KK, Valdes R Jr, Hartung BR, Linder MW. Individualizing warfarin therapy. Future Med. 2007;4:11-31
|
|
|
2007
|
47 |
12 |
p. 1590-1590
|
article
|
| 22 |
Highlightsand Book Review: Yengi LG, Leung L, Kao J. The evolving role of drug metabolism in drug discovery and development. Pharm Res. 2007;24:842-858. Testa B, Kramer S. The biochemistry of drug metabolism—an introduction: Part 1. Principles and overview. Chem Biodiversity. 2006;3:1053-1101. Testa B, Kramer S. The biochemistry of drug metabolism—an introduction: Part 2. Redox reactions and their enzymes. Chem Biodiversity. 2007;4:257-405
|
|
|
2007
|
47 |
12 |
p. 1591-1592
|
article
|
| 23 |
Highlightsand Book Review: Zandvliet AS, Huitema ADR, Copalu W, et al. CYP2C9 and CYP2C19 polymorphic forms are related to increased indisulam exposure of higher risk of severe hematologic malignancy. Clin Cancer Res. 2007;13:2970-2976
|
|
|
2007
|
47 |
12 |
p. 1592-1592
|
article
|
| 24 |
Pharmacodynamics and Pharmacokinetics of AMG 531, a Thrombopoiesis-Stimulating Peptibody, in Healthy Japanese Subjects: A Randomized, Placebo-Controlled Study
|
Kumagai, Yuji
|
|
2007
|
47 |
12 |
p. 1489-1497
|
article
|
| 25 |
Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects
|
Mousa, Shaker A.
|
|
2007
|
47 |
12 |
p. 1508-1520
|
article
|
| 26 |
Pharmacokinetics of Lenalidomide in Subjects With Various Degrees of Renal Impairment and in Subjects on Hemodialysis
|
Nianhang Chen,
|
|
2007
|
47 |
12 |
p. 1466-1475
|
article
|
| 27 |
Pharmacokinetics, Pharmacodynamics, and Safety of Tolvaptan, a Nonpeptide AVP Antagonist, During Ascending Single-Dose Studies in Healthy Subjects
|
Shoaf, Susan E.
|
|
2007
|
47 |
12 |
p. 1498-1507
|
article
|
| 28 |
Response to Comments on ACCP Position Statement on Microdosing
|
Bertino, Joseph S.
|
|
2007
|
47 |
12 |
p. 1597-1598
|
article
|
| 29 |
TherapeuticReview: Antiretroviral Drugs
|
Warnke, David
|
|
2007
|
47 |
12 |
p. 1570-1579
|
article
|
Journal description